Quarterly
Annual
| Unit: USD | 2025-08-29 | 2025-05-30 | 2025-02-28 | 2024-11-29 | 2024-08-30 | 2024-05-31 | 2024-03-01 | 2023-12-01 | 2023-08-25 | 2023-05-26 | 2023-02-24 | 2022-11-25 | 2022-08-26 | 2022-05-27 | 2022-02-25 | 2021-11-26 | 2021-08-27 | 2021-05-28 | 2021-02-26 | 2020-11-27 | 2020-08-28 | 2020-05-29 | 2020-02-28 | 2019-11-29 | 2019-08-30 | 2019-05-31 | 2019-03-01 | 2018-11-30 | 2018-08-31 | 2018-05-25 | 2018-02-23 | 2017-11-24 | 2017-08-25 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities | |||||||||||||||||||||||||||||||||
net income | 10,550,000 | 3,450,000 | 8,871,000 | 5,964,000 | -23,792,000 | 6,226,000 | -13,007,000 | -19,360,000 | -140,155,000 | -24,077,000 | -26,786,000 | 5,324,000 | 20,427,000 | 24,495,000 | 2,972,000 | 20,698,000 | 21,289,000 | -6,654,000 | 5,844,000 | 2,027,000 | 7,528,000 | 825,000 | -9,720,000 | 224,000 | 5,625,000 | 1,945,000 | 12,786,000 | 30,976,000 | 29,718,000 | 31,946,000 | 36,794,000 | 21,005,000 | -15,753,000 |
net income from discontinued operations | 0 | 0 | 0 | -8,148,000 | |||||||||||||||||||||||||||||
net income from continuing operations | 10,550,000 | 3,450,000 | 8,871,000 | 5,964,000 | -23,792,000 | 6,226,000 | -13,007,000 | -11,212,000 | |||||||||||||||||||||||||
adjustments to reconcile net income from continuing operations to net cash from operating activities: | |||||||||||||||||||||||||||||||||
depreciation expense and amortization of intangible assets | 13,206,000 | 14,012,000 | 14,037,000 | 14,961,000 | 15,381,000 | 15,525,000 | 17,156,000 | 17,654,000 | 10,612,000 | 21,300,000 | 19,931,000 | 19,789,000 | 16,446,000 | 16,571,000 | 16,077,000 | 15,813,000 | |||||||||||||||||
amortization of debt issuance costs | 673,000 | 917,000 | 950,000 | 953,000 | |||||||||||||||||||||||||||||
stock-based compensation expense | |||||||||||||||||||||||||||||||||
impairment of goodwill | 4,690,000 | 5,294,000 | 1,534,000 | 0 | |||||||||||||||||||||||||||||
change in fair value of contingent consideration | 4,100,000 | 14,800,000 | 6,400,000 | 3,700,000 | 0 | 124,000 | 24,000,000 | 17,200,000 | |||||||||||||||||||||||||
loss on extinguishment debt | |||||||||||||||||||||||||||||||||
deferred income taxes | -15,234,000 | 959,000 | -48,000 | 211,000 | -7,396,000 | -3,840,000 | 476,000 | -282,000 | -65,129,000 | -832,000 | 1,049,000 | 1,309,000 | -1,410,000 | 1,168,000 | -656,000 | 209,000 | |||||||||||||||||
other | 176,000 | -1,041,000 | -716,000 | -712,000 | 83,000 | -3,228,000 | -208,000 | 664,000 | 795,000 | -811,000 | 4,472,000 | -448,000 | -599,000 | -47,000 | 1,533,000 | -192,000 | |||||||||||||||||
changes in operating assets and liabilities: | |||||||||||||||||||||||||||||||||
accounts receivable | -15,400,000 | 37,880,000 | -54,755,000 | -23,885,000 | -39,901,000 | -42,124,000 | 872,000 | 48,658,000 | -31,963,000 | -13,746,000 | 78,529,000 | 129,695,000 | -56,019,000 | 34,089,000 | -39,526,000 | -36,053,000 | -35,985,000 | -25,537,000 | 12,012,000 | -1,930,000 | 5,537,000 | -13,395,000 | 9,198,000 | -13,688,000 | 27,582,000 | 91,430,000 | 5,669,000 | -89,441,000 | 31,409,000 | -45,799,000 | 14,894,000 | -55,801,000 | -3,535,000 |
inventories | -70,834,000 | 15,389,000 | 47,215,000 | -93,380,000 | 26,086,000 | -4,535,000 | 35,678,000 | -33,464,000 | -9,344,000 | 67,952,000 | 119,491,000 | -82,882,000 | 39,783,000 | -26,531,000 | -13,225,000 | 39,640,000 | -71,396,000 | -38,359,000 | -41,053,000 | 12,919,000 | 20,641,000 | -26,932,000 | -3,343,000 | -42,206,000 | 19,312,000 | 35,111,000 | 17,084,000 | 30,576,000 | -14,495,000 | -6,384,000 | -17,810,000 | -3,746,000 | -17,018,000 |
other assets | -6,088,000 | -1,979,000 | 15,015,000 | 705,000 | 14,801,000 | 15,424,000 | -23,229,000 | 2,102,000 | -1,900,000 | 15,391,000 | -1,525,000 | -5,199,000 | 4,531,000 | ||||||||||||||||||||
accounts payable and accrued expenses and other liabilities | -2,894,000 | 11,788,000 | 24,649,000 | 97,471,000 | -30,320,000 | 83,632,000 | -22,587,000 | 23,581,000 | 22,755,000 | -49,907,000 | -145,951,000 | -83,030,000 | |||||||||||||||||||||
payment of acquisition-related contingent consideration | 0 | 0 | 0 | 0 | 0 | -73,724,000 | |||||||||||||||||||||||||||
net cash from operating activities from continuing operations | -70,433,000 | 96,920,000 | 72,877,000 | 13,819,000 | -12,156,000 | 79,881,000 | -21,917,000 | 59,713,000 | |||||||||||||||||||||||||
net cash from operating activities from discontinued operations | 0 | 0 | -101,000 | 0 | -28,235,000 | ||||||||||||||||||||||||||||
net cash from operating activities | -70,433,000 | 92,821,000 | 72,877,000 | 13,819,000 | -12,156,000 | 79,780,000 | -21,917,000 | 31,478,000 | 36,799,000 | 41,038,000 | 100,535,000 | -73,985,000 | 20,906,000 | 36,714,000 | 32,165,000 | 15,146,000 | 48,022,000 | 49,338,000 | 20,421,000 | 35,569,000 | 24,978,000 | 13,626,000 | 23,334,000 | 25,267,000 | 48,941,000 | 46,310,000 | 39,054,000 | 35,352,000 | -9,384,000 | 28,337,000 | 34,697,000 | 14,257,000 | -9,639,000 |
cash flows from investing activities | |||||||||||||||||||||||||||||||||
capital expenditures and deposits on equipment | -2,925,000 | -1,916,000 | -2,335,000 | -1,836,000 | -5,795,000 | -3,777,000 | -5,204,000 | -4,648,000 | -1,899,000 | -13,260,000 | -12,613,000 | -11,649,000 | -8,855,000 | -9,156,000 | -7,376,000 | -12,766,000 | -7,563,000 | -5,222,000 | -20,151,000 | -14,644,000 | -15,556,000 | -7,521,000 | -4,210,000 | -5,158,000 | -3,321,000 | -10,496,000 | -6,232,000 | -13,384,000 | -7,487,000 | -7,794,000 | -4,418,000 | -6,039,000 | -14,894,000 |
proceeds from sales and maturities of investment securities | |||||||||||||||||||||||||||||||||
purchases of held-to-maturity investment securities | -12,939,000 | -12,733,000 | -12,671,000 | -20,723,000 | 1,000,000 | -1,000,000 | -11,034,000 | -8,469,000 | |||||||||||||||||||||||||
purchases of non-marketable investments | |||||||||||||||||||||||||||||||||
acquisition of business, net of cash acquired | 0 | 0 | -2,800,000 | -210,273,000 | -75,940,000 | 0 | |||||||||||||||||||||||||||
net cash from investing activities from continuing operations | 22,367,000 | -2,473,000 | -4,349,000 | -18,922,000 | -8,278,000 | 4,620,000 | -4,506,000 | -3,640,000 | |||||||||||||||||||||||||
net cash from investing activities from discontinued operations | 0 | 0 | 451,000 | 0 | 118,938,000 | ||||||||||||||||||||||||||||
net cash from investing activities | 22,367,000 | 25,877,000 | -4,349,000 | -18,922,000 | -8,278,000 | 5,071,000 | -4,506,000 | 115,298,000 | -48,747,000 | -12,826,000 | -13,353,000 | -223,643,000 | -8,926,000 | -9,210,000 | -7,457,000 | -13,377,000 | -15,770,000 | -33,780,000 | -20,000,000 | -14,628,000 | -15,306,000 | -7,463,000 | -4,156,000 | -5,116,000 | -79,251,000 | -10,478,000 | -6,348,000 | -13,363,000 | -49,599,000 | -7,759,000 | -4,352,000 | -6,039,000 | -14,668,000 |
cash flows from financing activities | |||||||||||||||||||||||||||||||||
repayments of debt | -224,703,000 | -75,000,000 | -37,211,000 | -14,423,000 | -4,485,000 | -8,153,000 | -4,507,000 | -4,489,000 | -2,073,000 | 0 | |||||||||||||||||||||||
payments to acquire common stock | |||||||||||||||||||||||||||||||||
net cash paid for settlement and purchase of capped calls | 0 | 0 | |||||||||||||||||||||||||||||||
distribution to noncontrolling interest | 0 | 0 | 0 | -1,470,000 | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
proceeds from debt | 0 | 0 | 0 | 295,287,000 | 7,882,000 | 0 | |||||||||||||||||||||||||||
proceeds from issuance of common stock | |||||||||||||||||||||||||||||||||
payment of premium in connection with convertible note exchange | 0 | 0 | |||||||||||||||||||||||||||||||
payment of preferred stock cash dividends | |||||||||||||||||||||||||||||||||
proceeds from issuance of convertible preferred stock, net of issuance costs | |||||||||||||||||||||||||||||||||
proceeds from borrowing under line of credit | 0 | 0 | 24,000,000 | 60,000,000 | |||||||||||||||||||||||||||||
fees paid for revolving line of credit financing | 0 | 0 | -469,000 | -299,000 | |||||||||||||||||||||||||||||
net cash from financing activities from continuing operations | -208,051,000 | -30,509,000 | 182,859,000 | -7,763,000 | -49,880,000 | -73,313,000 | -60,152,000 | -26,150,000 | |||||||||||||||||||||||||
net cash from financing activities from discontinued operations | 0 | 0 | 0 | -606,000 | |||||||||||||||||||||||||||||
net cash from financing activities | -208,051,000 | -30,509,000 | 182,859,000 | -7,763,000 | -49,880,000 | -73,313,000 | -60,152,000 | -26,756,000 | 18,702,000 | -4,634,000 | -39,631,000 | 261,979,000 | -34,331,000 | -9,516,000 | 105,363,000 | 12,363,000 | 1,554,000 | 32,169,000 | -30,496,000 | -378,000 | -157,000 | 909,000 | 15,889,000 | -4,047,000 | -670,000 | -83,000 | -860,000 | 1,713,000 | 22,535,000 | -4,100,000 | -3,258,000 | -7,233,000 | -11,169,000 |
effect of changes in currency exchange rates | 0 | -76,000 | -155,000 | -1,025,000 | |||||||||||||||||||||||||||||
net increase in cash, cash equivalents and restricted cash | -256,117,000 | 88,189,000 | 251,387,000 | -12,866,000 | 49,263,000 | -35,444,000 | |||||||||||||||||||||||||||
cash, cash equivalents and restricted cash at beginning of period | 0 | 0 | 0 | 383,477,000 | 0 | 363,065,000 | |||||||||||||||||||||||||||
cash, cash equivalents and restricted cash at end of period | -256,117,000 | 88,189,000 | 251,387,000 | 370,611,000 | 49,263,000 | 327,621,000 | |||||||||||||||||||||||||||
cash, cash equivalents and restricted cash at end of period: | |||||||||||||||||||||||||||||||||
continuing operations | -70,314,000 | 11,462,000 | -86,730,000 | 529,059,000 | |||||||||||||||||||||||||||||
discontinued operations | |||||||||||||||||||||||||||||||||
share-based compensation expense | 10,251,000 | 11,580,000 | 11,531,000 | 10,359,000 | 11,192,000 | 10,639,000 | 10,970,000 | 8,390,000 | 10,031,000 | 10,395,000 | 10,412,000 | 9,824,000 | 10,547,000 | 9,973,000 | 9,775,000 | ||||||||||||||||||
loss on extinguishment or prepayment of debt | |||||||||||||||||||||||||||||||||
proceeds from maturities of investment securities | 12,650,000 | 11,055,000 | 3,780,000 | 7,525,000 | 9,915,000 | 12,290,000 | 9,665,000 | ||||||||||||||||||||||||||
proceeds from issuance of preferred shares, net of 8,818 paid issuance costs | |||||||||||||||||||||||||||||||||
payments to acquire ordinary shares | -31,645,000 | -6,472,000 | -11,123,000 | -3,318,000 | -2,129,000 | -2,732,000 | -13,130,000 | -7,788,000 | -660,000 | -11,564,000 | -4,659,000 | -40,431,000 | -13,905,000 | -229,000 | -2,666,000 | ||||||||||||||||||
payment of preferred share cash dividends | -2,867,000 | ||||||||||||||||||||||||||||||||
proceeds from issuance of ordinary shares | 4,003,000 | 382,000 | 3,360,000 | 1,745,000 | 3,817,000 | 792,000 | 3,455,000 | 34,615,000 | 4,180,000 | 308,000 | 3,942,000 | 291,000 | 5,029,000 | ||||||||||||||||||||
proceeds from issuance of preferred shares, net of 8,702 paid issuance costs | |||||||||||||||||||||||||||||||||
repayments of borrowings under line of credit | 0 | 0 | -59,000,000 | -50,000,000 | |||||||||||||||||||||||||||||
amortization of debt discount and issuance costs | 817,000 | 968,000 | 1,042,000 | 1,010,000 | 937,000 | 1,048,000 | 1,069,000 | 2,787,000 | 2,706,000 | ||||||||||||||||||||||||
(gain) loss on extinguishment or prepayment of debt | 792,000 | ||||||||||||||||||||||||||||||||
net increase in cash and cash equivalents | 11,462,000 | -86,730,000 | 118,995,000 | 8,789,000 | -24,261,000 | 21,558,000 | 132,718,000 | 10,064,000 | 33,994,000 | 49,189,000 | -24,294,000 | 13,286,000 | -33,120,000 | 12,679,000 | 28,313,000 | 1,067,000 | |||||||||||||||||
cash and cash equivalents at beginning of period | 0 | 0 | 410,064,000 | 0 | 0 | 0 | 0 | 222,986,000 | 0 | 0 | 0 | 150,811,000 | 0 | 0 | 0 | 22,436,000 | 35,293,000 | ||||||||||||||||
cash and cash equivalents at end of period | 11,462,000 | -86,730,000 | 529,059,000 | 8,789,000 | -24,261,000 | 21,558,000 | 132,718,000 | 233,050,000 | 33,994,000 | 49,189,000 | -24,294,000 | 164,097,000 | -33,120,000 | 12,679,000 | 28,313,000 | 23,503,000 | 95,000 | ||||||||||||||||
cash and cash equivalents at end of period: | |||||||||||||||||||||||||||||||||
loss on extinguishment of debt | |||||||||||||||||||||||||||||||||
cash flows from operating activities: | |||||||||||||||||||||||||||||||||
adjustments to reconcile net income to net cash from operating activities: | |||||||||||||||||||||||||||||||||
(gain) loss on extinguishment of debt | 0 | ||||||||||||||||||||||||||||||||
cash flows from investing activities: | |||||||||||||||||||||||||||||||||
cash flows from financing activities: | |||||||||||||||||||||||||||||||||
effect of changes in currency exchange rates on cash and cash equivalents | -1,910,000 | 3,570,000 | 2,647,000 | -4,068,000 | |||||||||||||||||||||||||||||
effect of changes in currency exchange rates on cash, cash equivalents and restricted cash | 1,712,000 | 205,000 | |||||||||||||||||||||||||||||||
loss on remeasurement of capped calls | |||||||||||||||||||||||||||||||||
purchase of capped calls | |||||||||||||||||||||||||||||||||
supplemental disclosures: | |||||||||||||||||||||||||||||||||
interest paid, net of amounts capitalized | |||||||||||||||||||||||||||||||||
income taxes paid | |||||||||||||||||||||||||||||||||
amortization of operating lease right-of-use assets | 2,708,000 | 2,697,000 | 2,548,000 | 2,593,000 | 2,031,000 | 1,500,000 | 1,413,000 | 1,491,000 | 1,287,000 | 1,168,000 | 1,114,000 | ||||||||||||||||||||||
accounts payable and accrued expenses | -15,323,000 | 22,105,000 | -53,751,000 | ||||||||||||||||||||||||||||||
operating lease liabilities | -2,709,000 | -2,355,000 | -2,141,000 | -2,391,000 | -1,718,000 | -1,238,000 | -1,504,000 | -1,260,000 | -1,363,000 | -1,058,000 | -1,082,000 | ||||||||||||||||||||||
other current assets | 6,132,000 | -932,000 | |||||||||||||||||||||||||||||||
proceeds from issuance of shares | |||||||||||||||||||||||||||||||||
amortization of debt discounts and issuance costs | 2,332,000 | 2,295,000 | 2,196,000 | 2,191,000 | 2,116,000 | 2,080,000 | 2,005,000 | 1,047,000 | 734,000 | 718,000 | 706,000 | 694,000 | 685,000 | 807,000 | 714,000 | 722,000 | 729,000 | ||||||||||||||||
gain from change in fair value of contingent consideration | |||||||||||||||||||||||||||||||||
acquisitions of businesses, net of cash acquired | |||||||||||||||||||||||||||||||||
proceeds from issuance of debt | |||||||||||||||||||||||||||||||||
supplement disclosures: | |||||||||||||||||||||||||||||||||
depreciation and amortization | 15,308,000 | 8,793,000 | 8,367,000 | 8,633,000 | 8,818,000 | 9,435,000 | 9,544,000 | 9,054,000 | 6,817,000 | 6,927,000 | 6,408,000 | 7,526,000 | 6,028,000 | 6,358,000 | 6,270,000 | 25,392,000 | |||||||||||||||||
share-based compensation | 8,381,000 | 5,398,000 | 11,088,000 | 4,907,000 | 4,647,000 | 5,956,000 | 5,563,000 | 4,433,000 | 4,148,000 | 4,055,000 | 3,959,000 | 3,297,000 | 1,697,000 | 1,605,000 | 3,975,000 | ||||||||||||||||||
benefit from doubtful accounts receivable and sales returns | 525,000 | 6,000 | -9,000 | -122,000 | 74,000 | -100,000 | 73,000 | 46,000 | 34,000 | -104,000 | -80,000 | 39,000 | 28,000 | -256,000 | |||||||||||||||||||
deferred income tax benefit | -3,354,000 | 49,000 | 222,000 | -2,180,000 | 425,000 | 610,000 | -970,000 | -1,149,000 | 677,000 | -650,000 | 403,000 | -1,444,000 | -422,000 | -734,000 | -220,000 | -2,305,000 | |||||||||||||||||
gain on disposal of property and equipment | -5,000 | ||||||||||||||||||||||||||||||||
loss on mark-to-market adjustment of the capped call | 2,924,000 | ||||||||||||||||||||||||||||||||
income from mark-to-market adjustment of contingent consideration | |||||||||||||||||||||||||||||||||
prepaid expenses and other assets | 4,963,000 | -9,849,000 | -9,277,000 | 6,879,000 | -7,615,000 | 1,386,000 | 5,110,000 | -3,393,000 | -2,455,000 | 7,424,000 | -3,182,000 | -5,241,000 | -5,186,000 | -67,000 | 1,758,000 | 677,000 | |||||||||||||||||
accounts payable | 76,537,000 | 21,607,000 | 18,022,000 | -25,599,000 | 39,031,000 | -3,782,000 | 60,438,000 | -19,684,000 | -76,442,000 | -17,017,000 | 48,574,000 | -66,331,000 | 46,532,000 | -10,145,000 | 47,492,000 | -38,133,000 | |||||||||||||||||
other current and long-term liabilities | |||||||||||||||||||||||||||||||||
proceeds from sale of property and equipment | 55,000 | 151,000 | 16,000 | 250,000 | 58,000 | 54,000 | 42,000 | 10,000 | 18,000 | 32,000 | 21,000 | 204,000 | 35,000 | 226,000 | |||||||||||||||||||
repurchase of ordinary shares | 0 | ||||||||||||||||||||||||||||||||
proceeds from finep loan | 0 | ||||||||||||||||||||||||||||||||
proceeds from borrowings under revolving line of credit | 72,000,000 | 23,000,000 | 19,500,000 | 42,500,000 | 42,000,000 | 6,000,000 | 12,500,000 | 19,000,000 | 67,500,000 | 64,000,000 | 104,000,000 | 151,895,000 | 69,000,000 | 103,000,000 | 105,500,000 | 334,750,000 | |||||||||||||||||
repayments of borrowings under revolving line of credit | -47,000,000 | -23,000,000 | -19,500,000 | -42,500,000 | -42,000,000 | -6,000,000 | -12,500,000 | -19,000,000 | -67,500,000 | -64,000,000 | -104,000,000 | -184,184,000 | -69,000,000 | -103,000,000 | -105,500,000 | -334,750,000 | |||||||||||||||||
proceeds from issuance of ordinary shares from share option exercises | 5,659,000 | 2,546,000 | 1,337,000 | 554,000 | 134,000 | 641,000 | 1,166,000 | 1,300,000 | 297,000 | 1,071,000 | 2,402,000 | 1,326,000 | 1,993,000 | 3,638,000 | 539,000 | 58,000 | |||||||||||||||||
proceeds from issuance of ordinary shares from espp | 1,847,000 | 0 | 1,768,000 | 0 | 1,742,000 | 0 | 1,242,000 | ||||||||||||||||||||||||||
tax payments due upon issuance of ordinary shares for release of rsus | -337,000 | -151,000 | -3,483,000 | -96,000 | -282,000 | -351,000 | -20,000 | ||||||||||||||||||||||||||
long-term debt payments - term loan | 0 | ||||||||||||||||||||||||||||||||
long-term debt payments - bndes | -615,000 | ||||||||||||||||||||||||||||||||
purchase of capped call | 0 | ||||||||||||||||||||||||||||||||
proceeds from convertible notes due 2026, net of discount | 0 | 0 | |||||||||||||||||||||||||||||||
payment for extinguishment of long-term debt | 0 | 0 | |||||||||||||||||||||||||||||||
effect of exchange rate changes on cash and cash equivalents | 1,462,000 | 5,781,000 | -7,277,000 | 3,328,000 | -3,799,000 | 1,226,000 | 82,000 | 278,000 | |||||||||||||||||||||||||
supplemental disclosures of cash flow information: | |||||||||||||||||||||||||||||||||
cash paid during the period: | |||||||||||||||||||||||||||||||||
cash paid for interest | 443,000 | 3,044,000 | 185,000 | 5,058,000 | 4,696,000 | 5,760,000 | 4,930,000 | 5,016,000 | 4,942,000 | 4,243,000 | 3,567,000 | 3,958,000 | 3,523,000 | 15,834,000 | |||||||||||||||||||
cash paid for income taxes, net of refunds | 2,162,000 | 1,355,000 | 1,888,000 | 3,005,000 | 2,600,000 | 2,632,000 | 914,000 | 1,489,000 | 6,078,000 | 1,870,000 | 5,869,000 | 4,747,000 | 7,250,000 | 6,196,000 | 3,639,000 | 4,573,000 | |||||||||||||||||
noncash activities information: | |||||||||||||||||||||||||||||||||
fair value of non-cash consideration for acquisition of business | |||||||||||||||||||||||||||||||||
capital expenditures included in accounts payable at period end | 1,116,000 | 815,000 | 424,000 | -1,967,000 | 2,875,000 | -490,000 | 1,335,000 | -1,018,000 | 1,520,000 | -212,000 | 1,147,000 | 110,000 | 233,000 | -1,529,000 | 1,910,000 | -122,000 | |||||||||||||||||
unpaid debt fees related to convertible notes due 2026 | 875,000 | ||||||||||||||||||||||||||||||||
(gain) loss on disposal of property and equipment | -42,000 | 22,000 | |||||||||||||||||||||||||||||||
accrued expenses and other liabilities | 14,172,000 | -7,880,000 | -4,421,000 | 2,402,000 | 2,439,000 | 62,000 | 8,023,000 | -15,980,000 | 1,959,000 | 6,399,000 | 7,320,000 | -2,545,000 | 2,705,000 | -4,863,000 | 7,890,000 | ||||||||||||||||||
loss on disposal of property and equipment | 3,000 | -14,000 | |||||||||||||||||||||||||||||||
loss on mark-to-market adjustment of the capped calls | |||||||||||||||||||||||||||||||||
loss on extinguishment of debt / revolver | 0 | ||||||||||||||||||||||||||||||||
write-off of other assets | |||||||||||||||||||||||||||||||||
payment of costs related to ipo | |||||||||||||||||||||||||||||||||
proceeds from issuance of long-term debt, net of costs paid | |||||||||||||||||||||||||||||||||
effect of exchange rate changes on cash, cash equivalents and restricted cash | |||||||||||||||||||||||||||||||||
cash paid during the year: | |||||||||||||||||||||||||||||||||
reclassification of capped calls to shareholders' equity | |||||||||||||||||||||||||||||||||
fair value of ordinary shares issued and holdback in connection with acquisition | |||||||||||||||||||||||||||||||||
acquisition consideration held back to satisfy potential indemnification claims | |||||||||||||||||||||||||||||||||
fair value of contingent consideration for acquisition of business | |||||||||||||||||||||||||||||||||
unpaid debt fees related to term loan and revolver | 469,000 | ||||||||||||||||||||||||||||||||
long-term debt payments | |||||||||||||||||||||||||||||||||
effect of exchange rate changes on cash, cash equivalents and restricted cash * | -4,596,000 | -2,854,000 | -4,824,000 | 374,000 | 2,018,000 | ||||||||||||||||||||||||||||
net increase in cash, cash equivalents and restricted cash * | 30,471,000 | 13,250,000 | 30,925,000 | 32,220,000 | 25,720,000 | ||||||||||||||||||||||||||||
cash, cash equivalents and restricted cash at beginning of period * | 0 | 98,139,000 | 0 | 0 | 37,234,000 | ||||||||||||||||||||||||||||
cash, cash equivalents and restricted cash at end of period * | 30,471,000 | 111,389,000 | 30,925,000 | 32,220,000 | 62,954,000 | ||||||||||||||||||||||||||||
* cash balance was adjusted to include restricted cash upon adoption of asu 2016-18 in fiscal 2019. | |||||||||||||||||||||||||||||||||
long-term debt payment | -6,435,000 | -1,704,000 | -1,712,000 | -1,657,000 | -6,093,000 | -6,125,000 | -6,184,000 | -13,744,000 | |||||||||||||||||||||||||
benefit from doubtful accounts receivable | |||||||||||||||||||||||||||||||||
loss on early repayment of debt | |||||||||||||||||||||||||||||||||
issuance of ordinary shares from ipo, net of underwriting commissions | |||||||||||||||||||||||||||||||||
early debt payment for long-term debt | |||||||||||||||||||||||||||||||||
effect of exchange rate changes on cash, cash equivalents and restricted cash* | |||||||||||||||||||||||||||||||||
net increase in cash, cash equivalents and restricted cash* | |||||||||||||||||||||||||||||||||
cash, cash equivalents and restricted cash at beginning of period* | |||||||||||||||||||||||||||||||||
cash, cash equivalents and restricted cash at end of period* | |||||||||||||||||||||||||||||||||
fair value of warrants issued | |||||||||||||||||||||||||||||||||
ipo costs included in accounts payable and accrued liabilities at period end | 302,000 | -399,000 | |||||||||||||||||||||||||||||||
write off of long-term asset | |||||||||||||||||||||||||||||||||
payment of costs related to initial public offering | 0 | -302,000 | -1,289,000 | ||||||||||||||||||||||||||||||
proceeds from issuance of ordinary shares from employee share purchase plan | 1,335,000 | 0 | 968,000 | ||||||||||||||||||||||||||||||
withholding tax on restricted stock units | -11,000 | ||||||||||||||||||||||||||||||||
proceeds receivable from the exercise of stock options | -383,000 | ||||||||||||||||||||||||||||||||
restricted cash | |||||||||||||||||||||||||||||||||
issuance of ordinary shares from initial public offering (ipo), net of underwriting commissions | |||||||||||||||||||||||||||||||||
tax payments due upon issuance of ordinary shares for release of restricted stock units | |||||||||||||||||||||||||||||||||
extinguishment loss on long-term debt | |||||||||||||||||||||||||||||||||
warrants issued in connection with debt | |||||||||||||||||||||||||||||||||
write-off of deferred initial public offering costs | |||||||||||||||||||||||||||||||||
purchase of other assets | |||||||||||||||||||||||||||||||||
proceeds from escrow release related to sale of business | |||||||||||||||||||||||||||||||||
proceeds from long-term debt borrowing | |||||||||||||||||||||||||||||||||
distribution of share premium | |||||||||||||||||||||||||||||||||
payment for storage options related to escrow release | |||||||||||||||||||||||||||||||||
payment for strike price reductions | |||||||||||||||||||||||||||||||||
net decrease in cash and cash equivalents | |||||||||||||||||||||||||||||||||
amortization of debt original issuance discount | |||||||||||||||||||||||||||||||||
amortization of debt discount |
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
